RESPIRATORY SYNCYTIAL VIRUSES
Clinical trials for RESPIRATORY SYNCYTIAL VIRUSES explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUSES trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer RSV vaccine under the microscope: does it shield seniors from severe illness?
⭐️ VACCINE ⭐️ OngoingThis study reviews medical records to see how effective Pfizer's ABRYSVO vaccine is at preventing severe RSV lung infections in adults 60 and older. Researchers will analyze existing health data from routine doctor visits over several years. No new treatments or active participat…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUSES
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 17, 2026 07:09 UTC
-
Pregnant women's RSV shot shields newborns, new study confirms
⭐️ VACCINE ⭐️ OngoingThis study looks at how well the ABRYSVO vaccine works when given to pregnant people to protect their babies from RSV, a leading cause of serious lung infections in infants. Researchers will analyze medical records of babies up to 6 months old in Western Pennsylvania over several…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUSES
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 16, 2026 12:53 UTC